Study to Compare the Combination of Ribociclib Plus Goserelin Acetate With Hormonal Therapy Versus Combination Chemotherapy in Premenopausal or Perimenopausal Patients With Advanced or Metastatic Breast Cancer
Condition: Breast Cancer Interventions: Combination Product: Docetaxel / Capecitabine; Combination Product: Capecitabine / Vinorelbine; Combination Product: Paclitaxel / Gemcitabine; Drug: Ribociclib; Drug: Letrozole OR Anastrozole; Drug: Goserelin Sponsor: Novartis Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Arimidex | Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Hormonal Therapy | Hormones | Study | Xeloda